Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Erectile Dysfunction × osimertinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Other 1

Conditions

Carcinoma, Non-Small-Cell Lung 12 Lung Neoplasms 3 T790M Positive NSCLC Patients 1 Sexual Dysfunction, Physiological 1 NSCLC 1 Eunuchism 1 Erectile Dysfunction 1 EGF-R Positive Non-Small Cell Lung Cancer 1

Interventions

trametinib 1 sotorasib 1 selpercatinib 1 pembrolizumab 1 osimertinib 1 lorlatinib 1 dabrafenib 1 cemiplimab 1 brigatinib 1 alectinib 1 Pemetrexed 1 Paclitaxel 1 Nivolumab 1 Cyproterone Acetate 1 Carboplatin 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06532149 2024-08-09

EROS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Carcinoma, Non-Small-Cell Lung, Eunuchism, Erectile Dysfunction, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon ⚡